Feedback Share Price (FDBK)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Feedback Plc	LSE:FDBK	London	Ordinary Share	GB0003340550	ORD 0.25P

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	-0.05p	-1.71%	2.875p	5,104,207	09:09:12
Bid Price		Offer Price	High Price	Low Price	Open Price
2.80p		2.95p	3.375p	2.85p	3.15p

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Electronic & Electrical Equipment	0.5	-0.3	-0.1	-	8.10

Related Shares
Halma (HLMA), Renishaw (RSW), Sabien Technology (SNT), Flowgroup Plc (FLOW)

Feedback (FDBK) Latest News (2)

Feedback News

Date	Time	Source	Headline
27/4/2018	07:17	ALNCF	Alliance News Flash Headline
27/4/2018	07:00	UKREG	Feedback PLC Two-year contract with Royal Papworth Hospital
25/4/2018	14:05	UKREG	Feedback PLC Second Price Monitoring Extn
25/4/2018	14:00	UKREG	Feedback PLC Price Monitoring Extension
25/4/2018	10:37	ALNC	Feedback Shares Soar As It Pens Deal With General Electric Healthcare
17/4/2018	07:01	UKREG	Feedback PLC Holding(s) in Company
16/4/2018	12:38	ALNC	Feedback Simplifies Company Structure, Adds Merck Exec To Board
16/4/2018	07:30	UKREG	Feedback PLC New Company Structure and Directorate Change
16/4/2018	07:25	UKREG	Feedback PLC Appointment of non-executive director
09/4/2018	14:39	UKREG	Feedback PLC Holding(s) in Company

More Feedback News

Feedback Takeover Rumours

Feedback (FDBK) Share Charts

1 Year Feedback Chart

1 Month Feedback Chart

Intraday Feedback Chart

Feedback (FDBK) Discussions and Chat

Feedback Forums and Chat

Date	Time	Title	Posts
27/4/2018	09:18	**Feedback PLC**	1,648
03/2/2010	11:50	Feedback looks interesting - could easily be a ten bagger over next year	396
03/9/2002	11:53	ainsley long .........................quick shart it	2
21/3/2002	17:36	FEEDBACK+1.5p -GOOD VOLUME-Reversing trend	10

Add a New Thread

Feedback (FDBK) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
08:09:42	2.95	33,562	990.08	O
08:08:07	2.90	20,763	602.13	O
08:08:04	2.90	103,448	2,999.99	O
08:06:20	2.90	14,000	406.00	O
08:05:11	2.95	75,000	2,212.50	O

View all Feedback trades in real-time

Feedback (FDBK) Top Chat Posts

Date	Subject
27/4/2018 09:20	Feedback Daily Update: Feedback Plc is listed in the Electronic & Electrical Equipment sector of the London Stock Exchange with ticker FDBK. The last closing price for Feedback was 2.93p. Feedback Plc has a 4 week average price of 1.20p and a 12 week average price of 1.20p. The 1 year high share price is 4.13p while the 1 year low share price is currently 1.20p. There are currently 281,616,584 shares in issue and the average daily traded volume is 14,519,357 shares. The market capitalisation of Feedback Plc is £8,659,709.96. Read Full Thread Reply
25/4/2018 11:12	lr2: Hi Chopper, always nice to take a profit but I'm hanging on. This is going to be a really big one I reckon and the share price still doesn't reflect the future profit stream to me. I will be here for some time yet. Don't go away too long. Read Full Thread Follow Reply
16/4/2018 14:15	lr2: Apparently the daffodils are in 'full bloom' at TexRAD HQ. Share price in 'full bloom' next I hope. https://twitter.com/search?q=%23texrad&src=typed_query Read Full Thread Follow Reply
21/3/2018 09:57	lr2: Hi Duc, Nothing new in the podcast but very upbeat nevertheless. The two guys doing all the talking roughly said the following. TexRAD "hugely successful around the globe". Software spots conditions invisible to naked eye. Cadran - medical images archiving - in venture with Future Processing of Poland. Spinoff Stone Checker - royalties will come to Feedback. Investors perplexed by share price performance. Since CE Mark for TexRAD Lung price has declined from 5p. Reason - Trevor Brown selling down (see previous post #1390 for latest detail). Said TB likes new CEO David Crabb but believes board has too many members and none have skin in the game. With business at turning point DC & LM are likely to become significant shareholders in near future. The guys believe Feedback offers significant value and that there isn't a better time to buy in. Hope that helps. LR2. Read Full Thread Follow Reply
19/3/2018 18:54	ducatiman: He would be selling at a loss at these levels surely? It is obvious that he just wants to damage the company and its share price or he has an urgent need for cash! Read Full Thread Follow Reply
27/2/2018 17:54	lr2: Revenue for the half year was £229k but expectation for 2nd half of year is better so perhaps they will manage £500k+ for full year. Not enough to go without more financing but perhaps not a placing with the share price so weak. Some form of short term bank financing might be considered if share price remains weak and clinical sales come in soon. Whilst a placing is always likely it is not the only option. Probably won't have long to wait to find out the answer as to which way they will go. Read Full Thread Follow Reply
20/12/2017 12:58	lr2: What's likely happening here is a petulant old man with a very large holding is pished off with the board of directors now he is no longer a part of it. To hurt the company he used to be an integral part of, he has decided to sell vast numbers of his shares into the market rather than arrange an orderly market disposal, The result - a forcing down of the share price from 3.75p when he started selling to today's opening 1.6p. Even though he is losing vast amounts of money on his remaining holding he views that as worthwhile to his cause. If anyone has an alternative viewpoint on the man's sales then I'd be happy to hear it espoused here. Read Full Thread Follow Reply
20/12/2017 11:58	lr2: If TB continues at his current rate of selling 7 million shares a month, he will be done by mid April. What puzzles me is the effect his sales have had on his remaining holding and why he is apparently happy to let it continue. When he first started selling around 6 months back the share price was 3.75p - 4p. It is now 1.6p - 1.62p. In effect TB has reduced the value of his remaining 30.9 million shares by 2.15p a share thus lowering the value of the remaining shares by almost £665k. Why he persists in this self destructive behaviour one can only surmise for he could have arranged an orderly market disposal had he wished but he chose not to do so. I can only conclude his actions are a symbol of his petulance at the current board of directors for some perceived slight. Read Full Thread Follow Reply
11/12/2017 16:45	ydderf: Bear Case: The problem here is that there is unlikely to be any news of revenue over the next few months (unless you include research sales), and even if there are more CE applications approved that doesn't equate to revenue. Fact is the technology has been around for nearly three years in an AIM vehicle, the market cap of which has frequently been below £2m, and so by implication any potential acquirer has had lots of time to run the slide rule over it and consider an offer........Meanwhile the cash figures we have relate to 31st May. Undoubtedly they are lower now and revenue does not match expenses. As the months pass the probability of a further fund raise and dilution will come into focus. As far as I can see there are no constraints on the Board to issue more paper, they have hardly any skin in the game. Bull Case: The good news is that the success of this as an investment is not dependent on the 'caretaker' Board. A sales volcano may erupt beneath their feet but if so it will not have been of their doing. In addition to the in-house CE marked projects with e.g. Alliance, many research versions are now being used throughout the world to trial specific applications any one of which could result in a major diagnostic and commercial breakthrough. A typical project runs for two years plus, so any one of the research versions sold over two years ago could produce a result which nobody is anticipating. There is now a pipeline of such projects underway One modest commercial contract won would be a Richter event in relation to the puny market cap. As such, the share-price at this level is just option money Read Full Thread Follow Reply
08/12/2017 13:16	curlly: good to see the share price going up. Read Full Thread Follow Reply
22/11/2017 14:20	mikealig: A lot of shares but only worth around £750K at the current share price. As I mentioned before, the real key is whether the company is able to seriously monetise their technology. If they can, then this overhang could disappear in a flash. I'm not well enough informed to know what the potential clients would pay to license this technology. It sounds great but could anyone here put a figure on it? Read Full Thread Follow Reply

Feedback share price data is direct from the London Stock Exchange

Your Recent History

LSE

GKP

Gulf Keyst..

LSE

QPP

Quindell

FTSE

UKX

FTSE 100

LSE

IOF

Iofina

GBPUSD

UK Sterlin..

Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US Finance Manila

P:43 V: D:20180427 08:25:06